As we turn the page on a new year, the neuroendocrine cancer community isn’t just reflecting on progress—we’re looking ahead. This episode of NETWise explores where the field is going next, and what that future means for patients, caregivers, and clinicians alike.

Recorded in connection with the 2025 NETRF Neuroendocrine Cancer Research Symposium, this conversation brings together researchers, physicians, patient advocates, and NETRF leaders to examine the momentum shaping the years ahead.

In this episode, you’ll hear about:

• How emerging therapies—from PRRT advances to immune-based and cell therapies—are changing care
• Why precision medicine, surface targeting, and biomarkers are defining the next era of research
• NETRF’s research roadmap, focused on early detection, improved treatments, and precision medicine.
• The growing role of patient education, self-advocacy, and “thrivership” in living well with NETs and Neuroendocrine Carcinoma
• How collaboration across institutions and disciplines is accelerating progress toward better outcomes

This isn’t just a vision of the future—it’s the work already underway, and the direction the field is moving next.

Whether you’re a patient, caregiver, clinician, or advocate, this episode offers clear, accessible insights into the breakthroughs that’s driving the research forward.

Please like, share, and subscribe. Your engagement helps us reach more patients and caregivers seeking reliable neuroendocrine cancer information—and supports NETRF’s mission to expand research, awareness, and hope across the NET community.

Po-Hien Ear, PhD
Assistant Professor of Surgery (Surgical Oncology & Endocrine Surgery), University of Iowa Carver College of Medicine

Martyn Caplin, MD, PhD, FRCP
Professor of Gastroenterology & Tumour Neuroendocrinology, Royal Free Hospital & University College London (UCL)

Carl Gay, MD, PhD
Assistant Professor, Department of Thoracic/Head & Neck Medical Oncology
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Pamela L. Kunz, MD
Director, Center for Gastrointestinal Cancers, Smilow Cancer Hospital & Yale Cancer Center
Chief, GI Medical Oncology, Yale School of Medicine

Neil Renwick, MD, PhD, FRCPC
Assistant Professor, Department of Pathology & Molecular Medicine, Queen’s University
(SEAMO New Clinician-Scientist Program)

Nancy Joseph, MD, PhD
Professor of Surgical Pathology, University of California, San Francisco (UCSF)

Iacovos Michael, PhD

Sunnybrook Research institute and University of Toronto

Elsa Hadj Bachir, PhD

Research Fellow in Medicine Dana-Farber Cancer Institute

Thank you to NETRF staff members Elyse Gellerman and Anna Greene, PhD, and NETRF Board Members Josh Mailman, and Todd Gillman for their contributions to this episode.

A special thank you to Jake Dawson and Nancy Lewis for sharing their neuroendocrine cancer journeys.

The post Episode 51: A New Year— Where We’re Going appeared first on NETRF.